{"id":3182,"date":"2009-06-12T13:52:36","date_gmt":"2009-06-12T12:52:36","guid":{"rendered":"http:\/\/www.ethicalquote.com\/index.php\/2009\/06\/12\/novartis-rejects-call-for-vaccine-donations\/"},"modified":"2009-06-17T15:39:05","modified_gmt":"2009-06-17T14:39:05","slug":"novartis-rejects-call-for-vaccine-donations","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2009\/06\/12\/novartis-rejects-call-for-vaccine-donations\/","title":{"rendered":"Novartis rejects call for vaccine donations"},"content":{"rendered":"<p><a href=\"http:\/\/www.ft.com\/cms\/s\/875066ae-5902-11de-80b3-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F875066ae-5902-11de-80b3-00144feabdc0.html%3Fnclick_check%3D1&amp;_i_referer=&amp;nclick_check=1\" target=\"_blank\" title=\"090616_novartis.jpg\"><img decoding=\"async\" src=\"http:\/\/www.ethicalquote.com\/newTemplate\/wp-content\/uploads\/2009\/06\/090616_novartis.jpg\" title=\"090616_novartis.jpg\" alt=\"090616_novartis.jpg\" align=\"right\" \/><\/a><strong>Novartis<\/strong>, the Swiss pharmaceuticals group, defied the World Health Organisation and some of its corporate peers by ruling out a donation to the poor of vaccines to counter the latest flu pandemic, and saying developing nations or donor nations should cover the costs. Daniel Vasella, Novartis chief executive, told the Financial Times that he would consider offering discounted pricing to low-income nations, but unlike other drug companies, including <strong>GlaxoSmithKline<\/strong>, would not offer vaccines for free. He said: \u201cIf you want to make production sustainable, you have to create financial incentives.\u201d Image Source: static.guim.co.uk  &gt; <a href=\"http:\/\/www.ft.com\/cms\/s\/875066ae-5902-11de-80b3-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F875066ae-5902-11de-80b3-00144feabdc0.html%3Fnclick_check%3D1&amp;_i_referer=&amp;nclick_check=1\" target=\"_blank\">Continue.<\/a><\/p>\n<p>News selected by Covalence <span class=\"LinkBlueTransMedium\">| Country: Global<\/span><span class=\"LinkBlueTransMedium\"> | Company &#8211; <\/span><span lang=\"EN-GB\">EthicalQuote link<\/span><span class=\"LinkBlueTransMedium\">:<\/span><span class=\"LinkBlueTransMedium\"> <\/span><a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=7\" target=\"_blank\"><font class=\"tdtext\">Novartis<\/font><\/a><span class=\"LinkBlueTransMedium\"> | <\/span>Source: <a href=\"http:\/\/www.ft.com\/cms\/s\/875066ae-5902-11de-80b3-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F875066ae-5902-11de-80b3-00144feabdc0.html%3Fnclick_check%3D1&amp;_i_referer=&amp;nclick_check=1\" target=\"_blank\">Financial Times<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novartis, the Swiss pharmaceuticals group, defied the World Health Organisation and some of its corporate peers by ruling out a donation to the poor of vaccines to counter the latest flu pandemic, and saying developing nations or donor nations should cover the costs. Daniel Vasella, Novartis chief executive, told the Financial Times that he would&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[1],"tags":[11],"post_series":[],"class_list":["post-3182","post","type-post","status-publish","format-standard","hentry","category-news","tag-novartis","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/3182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=3182"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/3182\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=3182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=3182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=3182"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=3182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}